Julie K. Jang

817 total citations
32 papers, 503 citations indexed

About

Julie K. Jang is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Julie K. Jang has authored 32 papers receiving a total of 503 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 7 papers in Surgery and 7 papers in Molecular Biology. Recurrent topics in Julie K. Jang's work include Cancer Immunotherapy and Biomarkers (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Head and Neck Cancer Studies (4 papers). Julie K. Jang is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Head and Neck Cancer Studies (4 papers). Julie K. Jang collaborates with scholars based in United States, Australia and Finland. Julie K. Jang's co-authors include Alan L. Epstein, Melissa G. Lechner, Trevor E. Angell, Jonathan S. LoPresti, Adrian J. Correa, Sarah M. Russell, Garry S. Brody, Connor H. Church, Andrew Cuddihy and Shundi Ge and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Gastroenterology.

In The Last Decade

Julie K. Jang

26 papers receiving 496 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julie K. Jang United States 11 220 141 116 110 100 32 503
A. Fink-Retter Austria 12 155 0.7× 60 0.4× 95 0.8× 66 0.6× 136 1.4× 31 475
Krzysztof Misiukiewicz United States 15 307 1.4× 111 0.8× 343 3.0× 41 0.4× 108 1.1× 68 878
Longhao Sun China 10 161 0.7× 80 0.6× 48 0.4× 22 0.2× 192 1.9× 21 428
Mary Lou Ernest United States 10 345 1.6× 214 1.5× 50 0.4× 42 0.4× 149 1.5× 13 526
Olav Erich Yri Norway 10 218 1.0× 119 0.8× 31 0.3× 37 0.3× 58 0.6× 22 484
Maciej Kinalski Poland 13 97 0.4× 144 1.0× 97 0.8× 31 0.3× 177 1.8× 26 557
Ichiya Honma Japan 14 147 0.7× 166 1.2× 249 2.1× 33 0.3× 161 1.6× 28 576
Philippe C. Bishop United States 12 166 0.8× 66 0.5× 49 0.4× 25 0.2× 110 1.1× 17 499
Samuel Haywood United States 12 170 0.8× 111 0.8× 94 0.8× 16 0.1× 111 1.1× 49 545
Tim M. van der Sluis Netherlands 10 258 1.2× 215 1.5× 48 0.4× 102 0.9× 105 1.1× 21 613

Countries citing papers authored by Julie K. Jang

Since Specialization
Citations

This map shows the geographic impact of Julie K. Jang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie K. Jang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie K. Jang more than expected).

Fields of papers citing papers by Julie K. Jang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie K. Jang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie K. Jang. The network helps show where Julie K. Jang may publish in the future.

Co-authorship network of co-authors of Julie K. Jang

This figure shows the co-authorship network connecting the top 25 collaborators of Julie K. Jang. A scholar is included among the top collaborators of Julie K. Jang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie K. Jang. Julie K. Jang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maluf, Horacio, Bonnie Balzer, Evan Walgama, et al.. (2025). A review of histopathologic assessment for head and neck oncologists. Oral Oncology. 165. 107286–107286. 1 indexed citations
2.
Luu, Michael, Julie K. Jang, Alain C. Mita, et al.. (2024). Baseline weight recovery and mortality risk in head and neck cancer. Head & Neck. 47(1). 139–149. 1 indexed citations
3.
Walgama, Evan, Michael Luu, Julie K. Jang, et al.. (2024). Patient perceptions underlying ctDNA molecular surveillance for HPV(+) oropharyngeal squamous cell carcinoma. Oral Oncology. 156. 106894–106894.
4.
Burnison, M., Julie K. Jang, Stephen L. Shiao, et al.. (2023). Association of Left Anterior Descending Coronary Artery Calcium Progression and Radiation Dose with Major Adverse Cardiac Events in Breast Cancer. International Journal of Radiation Oncology*Biology*Physics. 117(2). e175–e175.
5.
Ho, Allen S., Michael Luu, Bonnie Balzer, et al.. (2023). Comparative impact of grade on mortality across salivary cancers: A novel, unifying staging system. Head & Neck. 45(8). 2028–2039. 8 indexed citations
6.
Nakamura, Brooke, et al.. (2023). CNSC-01. THE ROLE OF SEROTONERGIC RECEPTOR, HTR2B, ON MYELOID DERIVED SUPPRESSOR CELLS IN THE BRAIN METASTATIC ENVIRONMENT. Neuro-Oncology. 25(Supplement_5). v22–v22. 1 indexed citations
7.
Jang, Julie K., et al.. (2023). Fungal Depletion Bolsters Anti-Tumor Immune Response Elicited by Anti-PD1 Alone and in Combination with Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 117(2). S166–S166.
8.
Jang, Julie K., et al.. (2022). Deletion of monoamine oxidase A in a prostate cancer model enhances anti-tumor immunity through reduced immune suppression. Biochemical and Biophysical Research Communications. 634. 100–107. 9 indexed citations
9.
Jang, Julie K., et al.. (2019). Temporal Trends in the Utilization of Stereotactic Body Radiotherapy for Non-Small Cell Lung Cancer in the United States. International Journal of Radiation Oncology*Biology*Physics. 105(1). E511–E511. 2 indexed citations
10.
Sutcliffe, Simon, Shirin Kalyan, Darby Thompson, et al.. (2019). Novel Microbial-Based Immunotherapy Approach for Crohn's Disease. Frontiers in Medicine. 6. 170–170. 5 indexed citations
11.
Jang, Julie K., et al.. (2019). A Radiation Oncologist’s Guide to Axillary Management in Breast Cancer: a Walk Through the Trials. Current Breast Cancer Reports. 11(4). 293–302. 3 indexed citations
12.
Badash, Ido, et al.. (2017). Redefining Health: The Evolution of Health Ideas from Antiquity to the Era of Value-Based Care. Cureus. 9(2). e1018–e1018. 19 indexed citations
13.
Bressler, Brian, et al.. (2016). Mo1793 Clinical Trial Recruitment with Social Media - What to Expect. Gastroenterology. 150(4). S777–S778. 1 indexed citations
14.
Jang, Julie K., Leslie A. Khawli, Peisheng Hu, et al.. (2016). Systemic delivery of chTNT-3/CpG immunoconjugates for immunotherapy in murine solid tumor models. Cancer Immunology Immunotherapy. 65(5). 511–523. 10 indexed citations
15.
Jang, Julie K.. (2015). Phase 1 Dose-Escalation Study with LEC/Chtnt-3 and Toceranib Phosphate (Palladia) in Dogs with Spontaneous Malignancies. Journal of Cancer Science & Therapy. 7(6). 167–174. 2 indexed citations
16.
Angell, Trevor E., Melissa G. Lechner, Julie K. Jang, et al.. (2014). BRAF V600E in Papillary Thyroid Carcinoma Is Associated with Increased Programmed Death Ligand 1 Expression and Suppressive Immune Cell Infiltration. Thyroid. 24(9). 1385–1393. 108 indexed citations
17.
Angell, Trevor E., Melissa G. Lechner, Julie K. Jang, Jonathan S. LoPresti, & Alan L. Epstein. (2014). MHC Class I Loss Is a Frequent Mechanism of Immune Escape in Papillary Thyroid Cancer That Is Reversed by Interferon and Selumetinib Treatment In Vitro. Clinical Cancer Research. 20(23). 6034–6044. 120 indexed citations
18.
Russell, Sarah M., Melissa G. Lechner, Julie K. Jang, et al.. (2013). Establishment and Characterization of a new Human Extragonadal Germ Cell Line, SEM-1, and its Comparison With TCam-2 and JKT-1. Urology. 81(2). 464.e1–464.e9. 16 indexed citations
19.
Li, Zhongjun, Julie K. Jang, Melissa G. Lechner, et al.. (2012). Generation of tumor-targeted antibody–CpG conjugates. Journal of Immunological Methods. 389(1-2). 45–51. 12 indexed citations
20.
Cuddihy, Andrew, Shundi Ge, Lisa A. Kohn, et al.. (2012). Rapid Thymic Reconstitution Following Bone Marrow Transplantation in Neonatal Mice is VEGF-Dependent. Biology of Blood and Marrow Transplantation. 18(5). 683–689. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Fink-Retter Breakdown of academic impact, for papers by Krzysztof Misiukiewicz Breakdown of academic impact, for papers by Longhao Sun Breakdown of academic impact, for papers by Mary Lou Ernest Breakdown of academic impact, for papers by Olav Erich Yri Breakdown of academic impact, for papers by Maciej Kinalski Breakdown of academic impact, for papers by Ichiya Honma Breakdown of academic impact, for papers by Philippe C. Bishop Breakdown of academic impact, for papers by Samuel Haywood Breakdown of academic impact, for papers by Tim M. van der Sluis
Rankless by CCL
2026